Dedicated Phase 1 — Phoenix, Arizona

Dedicated Phase 1 is a clinical research site located in Phoenix, Arizona, United States 85013.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Dedicated Phase 1 has participated in 3 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus, Alzheimer's Disease, Age-Related Maculopathy.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dedicated Phase 1?

Dedicated Phase 1 has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dedicated Phase 1 conducted?

Dedicated Phase 1 has 3 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Alzheimer's Disease, Age-Related Maculopathy.

Is Dedicated Phase 1 accredited by Crixeo Health?

Dedicated Phase 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dedicated Phase 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.